#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polycystic liver disease Immune-mediated myositis Pituitary-dependent Cushing's syndrome Testicular leiomyosarcoma Ovarian cancer stage III Bronchopulmonary aspergillosis Arrhythmogenic right ventricular dysplasia Dent's disease Angiosarcoma recurrent Phaeochromocytoma Peripheral primitive neuroectodermal tumour of soft tissue Langerhans' cell histiocytosis Neuropathy peripheral Iron overload Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Fragile X syndrome VEXAS syndrome – Life with Disease Glomerulonephritis membranous – Life with Disease Chondrosarcoma – Diagnostics Piriformis syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Trials in Disease Amyotrophic lateral sclerosis Primary biliary cholangitis – Basic Information Congenital generalised lipodystrophy – Treatment KBG syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MORPHINE Abelacimab Nemolizumab Jk06 Perindopril Arginine Cls12311 Topiramate Immunoglobulins, Normal Human Autologous Microfat Aztreonam Ltx-315 Rbl035.2 Cytisine Cebsulfase Alfa Vrdn-001 Other Immunosuppressants Cpk850 Rineterkib Tucatinib Enalapril More therapies…

    Learn about Your Condition

    Proteus syndrome Contusion Peptostreptococcus infection Ectopic pregnancy Vitamin D deficiency Congenital ureteric anomaly Hepatic cirrhosis Epiphysiolysis Chorea Soft tissue sarcoma Prodromal Alzheimer's disease Muscle strain Pharyngeal cancer stage III Angiosarcoma metastatic Vulvovaginal candidiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer metastatic

  • Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Piflufolastat (18F)
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    Austria Belgium Czechia France Germany Greece +5

  • Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Dexamethasone
    • Gedatolisib
    France Spain

  • Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

    Recruiting

    3 1 1
    Investigated Drugs:
    • Darolutamide
    Belgium France Germany Ireland Italy The Netherlands +4

  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-dependent prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • BMS-986365
    Germany

  • Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Copper (64Cu) Chloride
    Italy

  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Copper (64Cu) Chloride
    Italy
Previous Page
1 2 3 4 5 6 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!